Resea Biotec is the official distributor

of Applikon Biotechnology in Switzerland. Applikon Biotechnology (part of Getinge since January 2020) is a world leader in developing and supplying advanced

bioreactor systems from laboratory scale to production scale. Together, we focus on supplying the best product offering for our customers now and in the long-term future. The portfolio of Applikon Biotechnology ranges from very small mini-bioreactors to large volume cultivation systems. Whether used for laboratory applications, good manufacturing practices, or the full scale-up process from lab to production, together, we have the right solution.

Applikon bioreactors used in search for COVID-19 vaccine

To control the pandemic SARS-CoV-2 outbreak, rapid development of a COVID-19 vaccine is needed as well as serological tests to determine whether or not someone has contracted the virus and has built up immunity. The baculovirus-insect cell expression system can be used to produce the SARS-CoV-2 spike protein for vaccine and serological test applications. To produce sufficient amounts of spike protein in a relatively short period of time, rapid screening for optimal process conditions is of utmost importance.

find out more

We are eager to receive your feedback

* Mandatory fields

Thank you for your message.

We will get in touch with you as soon as possible.